Jonathan Jacobs
Internal Medicine · Overland Park, KSNPI 1164458907
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 338 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,421 and has fallen 67.4% since, to $463 in 2025. Among internal medicine clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 338 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$938
- AbbVie$894
- Novo Nordisk$611
- Amgen$388
- Boehringer Ingelheim$318
- AstraZeneca$288
- plus $2K from 34 others
Across 48 payments — averaging $17,118 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$822K
What the payments were for
- Food & beverage$5,62399%
- Education$351%
- Other$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,688 in reported general payments places this provider in the 90th percentile of 705 internal medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 96 | $84,569 |
| OzempicSemaglutide | 36 | $38,576 |
| MounjaroTirzepatide | 27 | $30,868 |
| XareltoRivaroxaban | 21 | $20,366 |
| RytaryCarbidopa/Levodopa | 14 | $19,813 |
| JardianceEmpagliflozin | 26 | $19,760 |
| LinzessLinaclotide | 22 | $16,047 |
| MyrbetriqMirabegron | 13 | $13,952 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $13,493 |
| GemtesaVibegron | 16 | $13,336 |
| OxycontinOxycodone Hcl | 24 | $9,183 |
| Emgality SyringeGalcanezumab-Gnlm | 12 | $7,975 |
| PaxlovidNirmatrelvir/Ritonavir | 22 | $2,859 |
| Gabapentin | 90 | $2,239 |
| Memantine Hcl | 58 | $2,069 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $210 | $87,428118 claims |
| Novo NordiskOzempic | $611 | $38,57636 claims |
| Lilly USA, LLCMounjaro | $938 | $30,86827 claims |
| Amneal Pharmaceuticals LLCRytary, Levothyroxine Sodium | $69 | $20,700115 claims |
| Johnson & JohnsonXarelto | $103 | $20,36621 claims |
| Boehringer IngelheimJardiance | $318 | $19,76026 claims |
| AbbVieLinzess, Synthroid | $894 | $16,65533 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $26 | $13,33616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 705 internal medicine providers in Kansas.
Other internal medicine in Overland Park
- Herbert WaxmanOverland Park$82K
- Shadrach SmithOverland Park$27K
- David EdalatiOverland Park$21K
- Jennifer BrownOverland Park$9K
- Ammar KhalifaOverland Park$8K
- Bruce SalvaggioOverland Park$8K
- Vijaya SamuelOverland Park$8K
- Shazia Walijan MunirOverland Park$7K
- Matthew SwanOverland Park$7K
- Victoria WeaverOverland Park$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.